龍膽瀉肝湯이 Estradiol Valerate로 유발된 흰쥐의 다낭성 난소 발달과 수태에 미치는 영향

키워드

참고문헌 (60)

1. Roger P. Smith, "Netter's Obstetrics & Gynecology", pp.371~372 (2005), Women's Health
2. 김탁, "다낭성 난소 증후군의 최신지견", 대한산부인과학회. 연수강좌, 31, pp.38~44 (2002)
3. "The Rotterdam ESHRE", ASRM-sponsored PCOS consensus workshop group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome, 2004, pp.81, 19~25
4. 노정현, "다낭성 난소 증후군의 진단과 치료", 대한내분비학회. 연수강, 58~66 (2007)
5. 최영길, "내분비학", pp.563~571 (1994), 의학출판사
6. Abbott DH, "Developmental origin of polycystic ovary syndrome - a hypothesis", J Endocrinol, 1741, pp.1~5 (2002)
7. 陳貴廷, "實用中西醫結合診斷治療學", pp.1004~1009 (1991), 中國醫學科技出版社
8. 張鳳嬋, "中醫藥治療多囊卵巢綜合症方法初探", 新中醫, 1, pp.14~16 (1991)
9. 施令義, "中西醫結合硏究學術論文編", 婦産科專緝, 10, pp.32~ (1983)
10. 吳桂芳, "中醫藥治療多囊卵巢綜合症硏究槪況", 河南中醫, 14(2), pp.123~125 (1994)
11. 金維新, "不孕症的診斷與中醫治療", pp.172~177 (1992), 北京科學出版社
12. 周羽珍, "蔡小蓀治療婦科痼疾驗方拾萃", 江蘇中醫, 17(1), pp.9~10 (1996)
13. 양승정, "蒼附導痰湯이 estradiol valerate로 유발된 백서의 다낭성 난소에 미치는 影響", 대한한방부인과학회지, 15(2), pp.1~11 (2002), 대한한방부인과학회
14. 유영기, "腎氣丸合蒼附導痰湯이 Estradiol Valerate로 유도된 흰쥐의 다낭성 난소에 미치는 영향", 대한한방부인과학회지, 20(1), pp.77~92 (2007), 대한한방부인과학회
15. 남은정, "定經湯이 Estradiol Valerate로 유도된 흰쥐의 다낭성 난소에 미치는 영향", 대한한방부인과학회지, 20(1), pp.93~116 (2007), 대한한방부인과학회
16. 이연경, "歸脾湯이 Estradiol Valerate로 유도된 흰쥐의 다낭성 난소에 미치는 영향", 대한한방부인과학회지, 21(3), pp.60~74 (2008), 대한한방부인과학회
17. "Encyclopaedia Britannica, 제15판"
18. Brawer JR, "Development of the polycystic ovarian condition(PCO) in the estradiol valerate -treated rat", Biol Reprod, 35, pp.647~655 (1986)
19. 민응기, "다낭성 난소 증후군", Obstetrics & Gynecology Science, 51(8), pp.805~819 (2008), 대한산부인과학회
20. Stein IF, "Amenorrhea associated with bilateral polycystic ovaries", Am J Obstet Gynecol, 29, pp.181~191 (1935)
21. Barbieri RL, "The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism", Fertil Steril, 50, pp.197~212 (1988)
22. Frank S, "Polycystic ovary syndrome: a changing perspective", Clin Endocrinol, 31, pp.87~120 (1989)
23. Vink JM, "Heritability of polycystic ovary syndrome in a Dutch tein-family study", J Clin Endocrinol Metab, 91, pp.2100~2104 (2006)
24. 許俊, "東醫寶鑑", pp.823~824 (2005), 東醫寶鑑出版社
25. 신웅호, "착상과 내분비계", 대한산부인과학회지, 23(1), pp.11~18 (1980)
26. Nestler JE, "Insulin stimulates testosterone biosynthesis by human theca cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system", J Clin Endocrinol Metab, 83, pp.2001~2005 (1998)
27. Barbieri RL, "The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism", Fertil Steril, 50, pp.197~212 (1988)
28. Kalme T, "Comparative studies on the regulation of insulin-like growth factor-binding protain-1(IGFBP-1) and sex hormone-binding globulin (SHBG) production by insulin and insulin-like growth factors in human hepatoma cell", J Steroid Biochem Mol Biol, 86, pp.197~200 (2003)
29. Waldstreicher J, "Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization", J Clin Endocrinol Metab, 66, pp.165~172 (1988)
30. Stener-Victorin E, "Effects of electro-acupuncture on nerve growth factor and ovarian morphology in rats with experimentally induced polycystic ovaries", Biol Reprod, 63(5), pp.1497~1503 (2000)
31. 김인주, "다낭성 난소 증후군과 여성 건강", 대한내분비학회지, 10(3), pp.187~203 (2001)
32. Barbieri RL, "Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome: A common endocrinopathy with distinct pathophysiologic features", Am J Obstet Gynecol, 147(1), pp.90~101 (1983)
33. 이영호, "Medroxy Progesterone Acetate(MPA)가 생쥐의 교미 및 배란에 미치는 영향", 대한산부인과학회지, 20(8), pp.553~564 (1977)
34. Young, W.C, "Changes in selected features of behavior in pairs of opposely sexed chimpanzees during the sexual cycle and after ovariectomy", J. Comp. Psychol, 37, pp.107~ (1994)
35. 윤소영, "다낭성 난소 증후군 환자의 한방 치료에 대한 임상적 고찰", 대한한방부인과학회지, 13(2), pp.437~451 (2000)
36. 김동일, "다낭성 난소 증후군에 관한 문헌적 고찰", 대한한방부인과학회지, 10(1), pp.73~91 (1997)
37. Azziz R, "Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline", J Clin Endocrinol Metab, 91, pp.4237~4245 (2006)
38. 강길전, "여성생식의학", pp.219~226 (1998), 대관출판사
39. Carmina E, "Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome", Am J Obstet Gynecol, 167, pp.1807~1812 (1992)
40. Goldzieher JW, "The polycystic ovary. Ⅶ. Intractable uterine bleeding and endometrial hyperplasia possibly related to an extraovarian source of oestrogen", Acta Endocrinol (Copenh), 54, pp.452~466 (1967)
41. Balen AH, "Ultrasound assessment of the polycystic ovary: international consensus definitions", Hum Reprod Update, 9, pp.505~514 (2003)
42. 성연아, "다낭성 난소 증후군의 내과적 진단과 치료", 대한내과학회지, 70, pp.356~360 (2006)
43. Armanini D, "In-vivo metabolites of spironolactone and potassium canrenoate: determination of potential anti-androgenic activity by a mouse kidney cytosol receptor assay", Clin Endocrinol(Oxf), 23, pp.341~347 (1985)
44. Kousta E, "Modern use of climiphene citrate in induction of ovulation", Hum Reprod Update, 3(4), pp.359~365 (1997)
45. Hamilton-Fairley D, "Low-dose gonadotropin therapy for induction of ovulation in 100 women with polycystic ovary syndrome", Hum Reprod, 6, pp.1095~1099 (1991)
46. Biljan MM, "The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins", Fertil Steril, 84, pp.95~ (2005)
47. 李東垣, "東垣十種醫書", pp.219~220 (1983), 大星文化社
48. 羅元榿, "實用中醫婦科學", pp.271~275 (1994), 上海科學技術出版社
49. Lara HE, "Activation of ovarian sympathetic nerves in polycystic ovary syndrome", Endocrinology, 133(6), pp.2690~2695 (1993)
50. Nevi-Montalcini R, "The nerve growth factor 35 years later", Science, 237, pp.1154~1162 (1987)
51. Lara HE, "Involvement of nerve growth factor in female sexual development", Endocrinology, 126(1), pp.364~375 (1990)
52. Dissen GA, "A role for trkA nerve growth factor receptors in mammalian ovulation", Endocrinology, 137(1), pp.198~209 (1996)
53. Dissen GA, "Intraovarian excess of nerve growth factor increase androgen secretion and disrupts estrous cyclicity in the rat. Endocrinology", Endocrinology, 141(3), pp.1073~1081 (2000)
54. Dyer CA, "Norepinephrine amplifies human chorionic gonadotropin -stimulated androgen biosynthesis by ovarian theca-interstitial cells", Endocrinology, 116(4), pp.1645~1652 (1985)
55. Barria A, "Ovarian steroidal response to gonadotropins and beta -adrenergic stimulation is enhanced in polycystic ovarian syndrome:role of the sympathetic innervation", Endocrinology, 133(6), pp.2696~2703 (1993)
56. Hisano S, "Reciprocal synaptic relations between CRF-immunoreactive and TRH-immunoreactive neurons in the paraventricular nucleus of the rat hypothalamus", Brain Res, 620, pp.343~346 (1993)
57. Lenz HJ, "Central nervous system effects of corticotropin-releasing factor on gastrointestinal transit in the rat", Gastroenterology, 94, pp.598~602 (1988)
58. Stener-Victorin E, "Steroid- induced polycystic ovaries in rats: effect of electro-acupuncture on concentrations of endothelin-1 and nerve growth factor (NGF), and expression of NGF mRNA in the ovaries, the adrenal glands, and the central nervous system", Reprod Biol Endocrinol, 1, pp.33~ (2003)
59. Goldzieher JW, "The polycystic ovary. clinical and histological features", J Clin Endoc Metab, 22, pp.325~ (1963)
60. 이성수, "수정란 착상에 영향을 미치는 자궁내인자에 관한 연구", 대한수의학회지, 32(4), pp.531~542 (1992)

관련 논문AI추천